Trust Company of the South’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Sell
10,430
-133
-1% -$15.6K 0.19% 50
2026
Q1
$1.27M Buy
10,563
+225
+2% +$26K 0.2% 45
2025
Q4
$1.09M Sell
10,338
-1,379
-12% -$129K 0.18% 50
2025
Q3
$983K Sell
11,717
-14,016
-54% -$1.15M 0.16% 51
2025
Q2
$2.04M Sell
25,733
-174
-0.7% -$13.8K 0.36% 30
2025
Q1
$2.33M Buy
25,907
+37
+0.1% +$3.46K 0.49% 26
2024
Q4
$2.57M Sell
25,870
-394
-2% -$40.6K 0.52% 26
2024
Q3
$2.98M Buy
26,264
+2,087
+9% +$248K 0.63% 24
2024
Q2
$2.99M Buy
24,177
+14
+0.1% +$1.8K 0.71% 22
2024
Q1
$3.19M Sell
24,163
-2,340
-9% -$288K 0.74% 20
2023
Q4
$2.89M Buy
+26,503
New +$2.75M 0.76% 19

Other funds holding MRK

Trust Company of the South's MRK Position: Q2 2026 in Review

Trust Company of the South reduced its Merck (MRK) stake by 1.3% in Q2 2026, selling an estimated $15.6K and leaving 10,430 shares worth $1.34M. The position accounts for 0.19% of the portfolio, ranked #50.

Trust Company of the South first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.19M in Q1 2024. 2,532 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Trust Company of the South held 10,430 shares of Merck worth $1.34M as of Q2 2026.
  • Trust Company of the South sold 133 Merck shares in Q2 2026, an estimated $15.6K.
  • Merck made up 0.19% of Trust Company of the South's portfolio in Q2 2026, its #50 holding.
  • Trust Company of the South first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Trust Company of the South's Merck position peaked at $3.19M in Q1 2024.
  • 2,532 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Trust Company of the South's 13F filing for Q2 2026, filed 1 Jul 2026.